Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2009 1
2011 3
2012 2
2015 2
2016 3
2017 4
2018 5
2019 11
2020 11
2021 17
2022 23
2023 12
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

82 results

Results by year

Filters applied: . Clear all
Page 1
Evaluation of genetic variants associated with the risk of thiopurine-related pancreatitis: a case control study from ENEIDA registry.
Guerra I, Barros F, Chaparro M, Benítez JM, Martín-Arranz MD, de Francisco R, Piqueras M, de Castro L, Carbajo AY, Bermejo F, Mínguez M, Gutiérrez A, Mesonero F, Cañete F, González-Muñoza C, Calvo M, Sicilia B, Alfambra E, Rivero M, Lucendo AJ, Tardillo CA, Almela P, Bujanda L, van Domselaar M, Ramos L, Fernández Sánchez M, Hinojosa E, Verdejo C, Gimenez A, Rodríguez-Lago I, Manceñido N, Pérez Calle JL, Moreno MDP, Delgado-Guillena PG, Antolín B, Ramírez de la Piscina P, Casanova MJ, Soto Escribano P, Martín Arranz E, Pérez-Martínez I, Mena R, García Morales N, Granja A, Boscá Watts MM, Francés R, Fernández C, Calafat M, Roig-Ramos C, Vera MI, Carracedo Á, Domènech E, Gisbert JP; ENEIDA Project of GETECCU. Guerra I, et al. Among authors: martin arranz md. Dig Dis. 2024 Mar 7. doi: 10.1159/000537782. Online ahead of print. Dig Dis. 2024. PMID: 38452742
Incidence and Course of Joint Inflammation Associated with Inflammatory Bowel Disease in Patients Undergoing Treatment with Vedolizumab/Ustekinumab: The VEDUSTAR Study.
Gonzalez Diaz I, Gutierrez Riart M, Martin-Arranz MD, Plasencia Rodriguez C, Suarez Ferrer C, On Behalf Of Vedustar Research Team. Gonzalez Diaz I, et al. Among authors: martin arranz md. J Clin Med. 2024 Feb 14;13(4):1076. doi: 10.3390/jcm13041076. J Clin Med. 2024. PMID: 38398390 Free PMC article.
Genetic biomarkers of methotrexate response and safety in Crohn's disease: Data from the Spanish ENEIDA registry.
Salazar J, Garcia-Planella E, Fernández-Clotet A, Esteve M, Gisbert JP, Busquets D, Lucendo A, Márquez L, Guardiola J, Martín-Arranz MD, Iglesias E, Monfort D, Villoria A, Cañete F, Bell O, Ricart E, Zabana Y, Chaparro M, Domènech E, Gordillo J; ENEIDA registry of GETECCU. Salazar J, et al. Among authors: martin arranz md. Br J Clin Pharmacol. 2024 May;90(5):1301-1311. doi: 10.1111/bcp.16017. Epub 2024 Feb 18. Br J Clin Pharmacol. 2024. PMID: 38369687
Intensification with Intravenous Ustekinumab in Refractory Crohn's Disease.
Suárez Ferrer C, Arroyo Argüelles J, Rueda García JL, García Ramírez L, Martin Arranz E, Sánchez Azofra M, Poza Cordón J, Noci Belda J, Martin-Arranz MD. Suárez Ferrer C, et al. Among authors: martin arranz md. J Clin Med. 2024 Jan 24;13(3):669. doi: 10.3390/jcm13030669. J Clin Med. 2024. PMID: 38337361 Free PMC article.
Real-world long-term effectiveness of ustekinumab in ulcerative colitis: results from a spanish open-label cohort.
Iborra M, Ferreiro-Iglesias R, Maria Dolores MA, Mesonero Gismero F, Mínguez A, Porto-Silva S, García-Ramírez L, García de la Filia I, Aguas M, Nieto-García L, Suárez Ferrer C, Bastida G, Barreiro-De-Acosta M, Nos P. Iborra M, et al. Among authors: maria dolores ma. Scand J Gastroenterol. 2024 Mar;59(3):260-268. doi: 10.1080/00365521.2023.2278427. Epub 2023 Nov 6. Scand J Gastroenterol. 2024. PMID: 37933161
Initial Management of Intra-abdominal Abscesses and Preventive Strategies for Abscess Recurrence in Penetrating Crohn's Disease: A National, Multicentre Study Based on ENEIDA Registry.
Casas Deza D, Polo Cuadro C, de Francisco R, Vela González M, Bermejo F, Blanco I, de la Serna Á, Bujanda L, Bernal L, Rueda García JL, Gargallo-Puyuelo CJ, Fuentes-Valenzuela E, Castro B, Guardiola J, Ladrón G, Suria C, Sáez Fuster J, Gisbert JP, Sicilia B, Gomez R, Muñoz Vilafranca C, Barreiro-De Acosta M, Peña E, Castillo Pradillo M, Cerrillo E, Calvet X, Manceñido N, Monfort I Miquel D, Marín S, Roig C, Marce A, Ramírez de Piscina P, Betoré E, Martin-Cardona A, Teller M, Alonso Abreu I, Maroto N, Frago S, Gardeazabal D, Pérez-Martínez I, Febles González ÁD, Barrero S, Taxonera C, García de la Filia I, Ezkurra-Altuna A, Madero L, Martín-Arranz MD, Gomollón F, Domènech E, García-López S. Casas Deza D, et al. Among authors: martin arranz md. J Crohns Colitis. 2024 Apr 23;18(4):578-588. doi: 10.1093/ecco-jcc/jjad184. J Crohns Colitis. 2024. PMID: 37930823
Mirikizumab as Induction and Maintenance Therapy for Ulcerative Colitis.
D'Haens G, Dubinsky M, Kobayashi T, Irving PM, Howaldt S, Pokrotnieks J, Krueger K, Laskowski J, Li X, Lissoos T, Milata J, Morris N, Arora V, Milch C, Sandborn W, Sands BE; LUCENT Study Group. D'Haens G, et al. N Engl J Med. 2023 Jun 29;388(26):2444-2455. doi: 10.1056/NEJMoa2207940. N Engl J Med. 2023. PMID: 37379135 Clinical Trial.
Current management of bowel failure due to Crohn's disease in Spain: Results of a GETECCU survey.
Suárez Ferrer C, Martín-Arranz MD, Martín-Arranz E, Rodríguez Morata F, López García A, Benítez Cantero JM, Mesonero Gismero F, Barreiro-de Acosta M. Suárez Ferrer C, et al. Among authors: martin arranz md. Gastroenterol Hepatol. 2023 Jun-Jul;46(6):439-445. doi: 10.1016/j.gastrohep.2022.10.008. Epub 2022 Oct 29. Gastroenterol Hepatol. 2023. PMID: 37221906 English, Spanish.
82 results